Balancing act: the health advantages of naturally-occurring hormones in hormone replacement therapy : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, second session, July 22, 2004
United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness
U.S. Government Printing Office, 2005 - Hormone therapy - 101 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
actually alternative Alving approved associated believe benefits better bio-identical biologically identical hormones blood body breast cancer breast cancer risk Brownstein Burton cause Center chemical clinical compounding pharmacies continued controlled death Director doctors don't doses drugs effects endometrial estradiol estriol estrogen estrone evidence experience follows Fugh-Berman give going hearing heart disease higher hormone replacement therapy hormone therapy hot flashes Hotze human hypothyroidism increased individual Institute International it's levels look lower manufacturers medicine menopause myocardial infarction natural hormones Network never normal NWHN occur patients physician placebo postmenopausal women practice prepared prescribed prescription prevent problems progesterone progestin safety showed side effects statement stroke Subcommittee symptoms synthetic hormones talk term testosterone tests Thank thing treat treatment trial Watson woman Women's Health Women's Health Initiative
Page 35 - Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D.
Page 2 - Members' and witnesses' written and opening statements be included in the record, and without objection, so ordered. I ask unanimous consent that all articles, exhibits and extraneous or tabular material referred to be included in the record, and without objection, so ordered. I...
Page 15 - National Institutes of Health US Department of Health and Human Services For Release on Delivery Expected at 10:00 AM Thursday, June 30,2005 46 Introduction Mr.
Page 2 - JUNE 24, 2004 HOUSE OF REPRESENTATIVES, SUBCOMMITTEE ON HUMAN RIGHTS AND WELLNESS, COMMITTEE ON GOVERNMENT REFORM, Washington, DC. The subcommittee met, pursuant to notice, at 2:40 pm, in room 2154, Rayburn House Office Building, Hon.
Page 36 - Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial.
Page 36 - Shumaker SA, Legault C, Kuller L, Rapp SR, Thai L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH.
Page 35 - Effects of estrogen plus progestin on health-related quality of life.